Related Experiment Video

Updated: Oct 16, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Radiotherapy for choroidal neovascularisation of age-related macular degeneration: a fresh perspective

U Chakravarthy1

  • 1Queen's University, Belfast, Northern Ireland, UK. u.chakravarthy@qub.ac.uk

Eye (London, England)
|June 9, 2000
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Related Experiment Videos

Last Updated: Oct 16, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Articles linked to this work by shared authors, journal, and citation graph.

Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years.

Eye (London, England)·2021

An overview of the clinical applications of optical coherence tomography angiography.

Eye (London, England)·2017

Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.

Eye (London, England)·2017

Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.

BMJ open·2016

Clinical features and long-term progression of reticular pseudodrusen in age-related macular degeneration: findings from a multicenter cohort.

Eye (London, England)·2016

The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care.

Eye (London, England)·2016

Personalised ILM peeling for Myopic traction maculopathy.

Eye (London, England)·2026

Prelaminar hyperreflective lines in non-arteritic anterior ischaemic optic neuropathy.

Eye (London, England)·2026

Post-treatment residual masses in orbital lymphoma: incidence, risk factors, and prognostic impact.

Eye (London, England)·2026

Deep learning-based prediction of one-year functional and structural outcomes in treatment-naïve DMO after anti-VEGF therapy.

Eye (London, England)·2026

Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics.

Eye (London, England)·2026

Identification of a translatable rabbit model for corneal endothelial dysfunction.

Eye (London, England)·2026

Interplay Between Epigenetics and Reactive Oxygen Species in Tumor Radioresistance: Mechanisms and Therapeutic Strategies for Radiotherapy.

Cancer medicine·2026

Direct probabilistic IMPT treatment planning with setup and range errors for neuro-oncological patients.

Physics in medicine and biology·2026

CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas (RPS).

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026

Nanoparticle-Enabled Immune-Dose Shaping in Breast Cancer Radiotherapy: Reconciling Tumor Immunogenicity with Systemic Immune Preservation.

International journal of molecular sciences·2026

Constant Light Versus Intermittent Constant Light/Recovery Regimen: Differential Effects on Pineal Ultrastructure, Clock Gene Protein Abundance, and Systemic Metabolism in Rats.

International journal of molecular sciences·2026

Regulation of Intestinal P-Glycoprotein by Gamma-Ray Irradiation: Impacts on Transporter Expression and Oxidative Stress.

International journal of molecular sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us